Aguilon, Sylvia A.
HRN: 23-35-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
METRONIDAZOLE 500MG (TAB)
07/17/2023
07/30/2023
ORAL
500mg
TID
H Pylori Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes